Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03586570
What this trial is testing

Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 20
Early research (Phase 1)Study completedNCT05800444
What this trial is testing

Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants

Who this might be right for
Chronic Kidney DiseaseHealthy Volunteers
Bayer 24
Early research (Phase 1)Study completedNCT02706834
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

Who this might be right for
Dose Finding Study
Takeda 36
Early research (Phase 1)Study completedNCT06542536
What this trial is testing

A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men

Who this might be right for
Obesity
Novo Nordisk A/S 73
Early research (Phase 1)Study completedNCT04713930
What this trial is testing

JNJ-61393215 in Healthy Japanese Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT07464535
What this trial is testing

A Single-Dose, Randomized, Open-Label, 2-Way Crossover Study to Evaluate the Dose-Proportionality, Safety, and Tolerability of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) in Healthy Japanese and Chinese Subjects

Who this might be right for
Healthy Subjects (HS)
Tonix Pharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT03310021
What this trial is testing

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

Who this might be right for
Bleeding
Portola Pharmaceuticals 108
Early research (Phase 1)Study completedNCT03542344
What this trial is testing

This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated.

Who this might be right for
Healthy
Boehringer Ingelheim 16
Early research (Phase 1)Study completedNCT02005211
What this trial is testing

A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers

Who this might be right for
Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers
AstraZeneca 114
Early research (Phase 1)Study completedNCT06515834
What this trial is testing

Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Japanese Persons

Who this might be right for
Gastroenterology
Ferring Pharmaceuticals 24
Early research (Phase 1)Study completedNCT01177943
What this trial is testing

A Bioequivalence (BE) Study in Healthy Subjects

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 42
Early research (Phase 1)Study completedNCT00854009
What this trial is testing

Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 40
Early research (Phase 1)Study completedNCT04994106
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers

Who this might be right for
Healthy Participants
AstraZeneca 98
Early research (Phase 1)WithdrawnNCT00549263
What this trial is testing

Bioequivalence Study of SB797620 in Healthy Japanese Volunteers

Who this might be right for
Healthy Subjects
GlaxoSmithKline
Early research (Phase 1)Study completedNCT02161588
What this trial is testing

A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 48
Early research (Phase 1)Study completedNCT05038787
What this trial is testing

LY3473329 in Healthy Japanese Participants

Who this might be right for
Healthy
Eli Lilly and Company 24
Early research (Phase 1)Study completedNCT01958047
What this trial is testing

Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability

Who this might be right for
PharmacokineticsPharmacodynamicsHealthy Subjects+1 more
Astellas Pharma Europe B.V. 64
Early research (Phase 1)Study completedNCT04365218
What this trial is testing

Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
AstraZeneca 12
Early research (Phase 1)Study completedNCT04914520
What this trial is testing

Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects

Who this might be right for
Respiratory Syncytial Virus Infections
Daiichi Sankyo Co., Ltd. 48
Early research (Phase 1)Study completedNCT03361540
What this trial is testing

ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects

Who this might be right for
Healthy Subjects
Astellas Pharma Inc 56
Next Page